Prevalence of Osteoporosis in Patients After Renal Transplantation: Results from a Single Center
Article Outline
Background
Osteopenia and bone loss are major complications after renal transplantation. Clinical data in the Asian population are lacking.
Methods
We prospectively studied the changes in bone mineral density (BMD) of 31 cadaveric renal allograft recipients using dual energy X-ray absorptiometry (DEXA) within 2 weeks after transplantation and then at 1 year post transplantation.
Results
One year after transplantation, the mean bone mineral reduction at the lumbar spine was 6.3 ± 4.9% (osteopenia in 32.2% of patients and osteoporosis in 6.5%). For the femoral neck, there was a 4.3 ± 5.5% decrease in BMD (osteopenia in 38.7% of patients and osteoporosis in 3.2%). For total hip, there was a 4.8 ± 3.6% decrease in BMD (osteopenia in 25.8% of patients and osteoporosis in 3.2%). Decrease in BMD at the femoral neck and total hip correlated with the cumulative dosage of steroid (femoral neck: r = −0.36, p = 0.048; total hip: r = −0.4, p = 0.026). Compared with patients without rejection, patients with a history of acute rejection received higher cumulative doses of steroid, and sustained a greater decrease in BMD at the femoral neck and total hip: median percentage (interquartile range) decrease in femoral neck BMD was 7.7% (−12.8 to −6.3) versus 4.4% (−6.5 to −0.065), p = 0.016; decrease in total hip BMD was 8.2% (−11.22 to −6.7) versus 3.4% (−6.92 to −1.4), p = 0.03. There was no correlation between BMD changes and cumulative dosage of cyclosporine A, azathioprine, tacrolimus, duration of dialysis, changes in body mass index, creatinine or parathyroid hormone levels.
Conclusion
Reduction of BMD after renal transplantation is common. The cumulative dosage of prednisolone correlates with bone loss at the femoral neck and total hip. Patients with a history of acute rejection suffered from more bone loss after 1 year compared to patients without rejection.
Key words: bone mineral density , osteopenia , osteoporosis , prednisolone , renal transplantation
No full text is available. To read the body of this article, please view the PDF online.
References
- . Rapid loss of vertebral mineral density after renal transplantation . N Engl J Med . 1991;325:544–550
- . Changes in bone mass early after kidney transplantation . J Bone Miner Res . 1994;9:1–9
- . Loss of regional bone mineral density in the first 12 months following renal transplantation . Nephron . 1994;66:52–57
- . Osteoporosis after organ transplantation . Am J Med . 1998;104:456–469
- . Organ transplantation and osteoporosis . Curr Opin Rheumatol . 1995;7:255–261
- . Bone mineral density after renal transplantation: long-term follow-up . Transplant Proc . 1999;31:2322–2323
- Factors involved in the loss of bone mineral density after renal transplantation . Transplant Proc . 1995;27:2224–2225
- . Bone mineral density after renal transplantation . Transplant Proc . 1998;30:3029–3030
- . Osteoporosis after renal transplantation: single center experience . Transplantation . 2001;71:645–649
- . The natural history and surgical treatment of hypercalcemia before and after renal transplantation . Surg Gynecol Obstet . 1982;154:481–490
- . Bone mineral density after kidney transplantation . Transplantation . 1995;59:982–986
- . Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation . Transplant Proc . 1996;28:1561–1564
- . Long term bone loss after renal transplantation: comparison of immunosuppressive regimens . Clin Transplant . 1995;9:20–24
- . Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study . Am J Kidney Dis . 1996;28:105–114
- Positive effects of kidney transplantation on bone mass . Transplant Proc . 1998;30:3031–3033
- Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients . Nephrol Dial Transplant . 1995;10:2096–2100
- . Bone mass and mineral metabolism in kidney transplant patients . Transplant Proc . 2002;34:407
- Bone mineral density and fracture prevalence in long term kidney graft recipients . Transplantation . 2002;74:496–500
- . The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine . Transplant Proc . 1999;31:1366–1369
- Impact of spinal degenerative changes on the evaluation of bone mineral density with dual x-ray absorptiometry . Calcif Tissue Int . 1997;60:430–433
- The deleterious effects of long term cyclosporine A, cyclosporine G and FK 506 on bone mineral metabolism In vivo . Transplantation . 1994;57:1231–1237
- Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study . J Heart Lung Transplant . 1998;17:1089–1096
- Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation . Am J Respir Crit Care Med . 2000;162:941–946
- . Pamidronate therapy as prevention of bone loss following renal transplantation . Kidney Int . 2000;57:684–690
- . High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation . J Am Soc Nephrol . 2000;11:1093–1099
- . Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate . J Am Soc Nephrol . 2003;14:2669–2676
- . Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate . J Am Soc Nephrol . 2001;12:1164–1172
- . Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients . Transplant Proc . 1996;28:3485–3487
- Salmon calcitonin prevents Cyclosporin A induced high turnover bone loss . Endocrinology . 1991;129:92–98
- Treatment of osteopenia and osteoporosis after kidney transplantation . Transplantation . 1998;66:1004–1008
- Osteoporosis in chronic kidney disease . Am J Kidney Dis . 2004;43:566–571
PII: S1561-5413(09)60217-9
doi:10.1016/S1561-5413(09)60217-9
© 2005 The Hong Kong Society of Nephrology. Published by Elsevier Inc. All rights reserved.
